Evaluation of cognition in cancer patients: Special focus on the elderly

Critical Reviews in Oncology/Hematology

Volumn 60, Issue 3, 2006, Pages 242-255

  Bial, Andrea K ^a   Schilsky, Richard L ^a   Sachs, Greg A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cancer; Cognition; Delirium; Dementia; Elderly

Indexed keywords

AGING; BREAST CANCER; CANCER PATIENT; COGNITIVE DEFECT; DISEASE ASSOCIATION; HUMAN; LEUKEMIA; LUNG CANCER; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; NEUROPSYCHOLOGICAL TEST; ONCOLOGY; POPULATION RESEARCH; POPULATION SIZE; REVIEW; SYSTEMATIC REVIEW;

AGED; COGNITION DISORDERS; HUMANS; NEOPLASMS;

EID: 33751240827     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2006.05.002     Document Type: Review

References (33)

1. Department of Health and Human Services. Administration on aging's census 2000 special tabulation on aging. http://www.aoa.gov. Accessed April 13, 2005.
2. Extermann M., Aapro M., Bernabei R., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55 (2005) 241-252
3. Ries L.A.G., Reichman M.E., Lewis D.R., et al. Cancer survival and incidence from the surveillance, epidemiology, and end results (SEER) program. The Oncologist 8 (2003) 541-552
4. Murphy V.H., Krumholz H.M., and Gross C.P. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291 (2004) 2720-2726
5. Lewis J.H., Kilgore M.L., Goldman D.P., et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21 (2003) 1383-1389
6. Chen H., Cantor A., Meyer J., et al. Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer 97 (2003) 1107-1114
7. Kimmick G.G., Peterson B.L., Kornblith A.B., et al. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing educational intervention with standard information: CALGB 360001. J Clin Oncol 23 (2005) 2201-2207
8. Cohen H.J. The oncology geriatric education retreat: commentary and conclusions. Cancer 80 (1997) 1354-1356
9. Workshop report: exploring the role of cancer centers for integrating aging and cancer research. http://nia.nih.gov/health/nianci/summary.asp. Accessed March 12, 2003.
10. ASCO Geriatric Oncology Symposium. Cancer Care in the Elderly: An Integrated Approach (2000)
11. Minisini A., Atalay G., Bottomley A., et al. What is the effect of systemic anticancer treatment on cognitive function?. Lancet Oncol 5 (2004) 273-282
12. Tannock I.F., Ahles T.A., Ganz P.A., and van Dam F.S. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22 (2004) 2233-2239
13. Wefel J.S., Lenzi R., Theriault R., et al. 'Chemobrain' in breast carcinoma? A prologue. Cancer 101 3 (2004) 466-475
14. Ahles T., and Saykin A. Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest 19 (2001) 812-820
15. Alzheimer's association. Statistics about Alzheimer's Disease. http://www.alz.org/statistics. Accessed May 3, 2003.
16. Evans D.A., Funkenstein H.H., Albert M.S., et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 262 (1989) 2552-2556
17. Inouye S.K., Viscoli C.M., Horwitz R.I., et al. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Int Med 119 (1993) 474-481
18. Inouye S.K., Bogardus S.T., Charpentier P.A., et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340 (1999) 669-676
19. Francis J., Martin D., and Kapoor W.N. A prospective study of delirium in hospitalized elderly. JAMA 263 (1990) 1097-1101
20. Sternberg S.A., Wolfson C., and Baumgarten M. Undetected dementia in community-dwelling older people: the Canadian study of health and aging. J Am Geriatr Soc 48 (2000) 1430-1434
21. Inouye S.K., Foreman M.D., Mion L.C., et al. Nurses' recognition of delirium and its symptoms: comparison of nurse and researcher ratings. Arch Int Med 161 (2001) 2467-2473
22. Callahan C.M., Hendrie H.C., and Tierney W.M. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Int Med 122 (1995) 422-429
23. Valcour V.G., Masaki K.H., Curb D.J., et al. The detection of dementia in the primary care setting. Arch Int Med 160 (2000) 2964-2968
24. Chodosh J., Petitti D.B., Elliott M., et al. Physician recognition of cognitive impairment: evaluating the need for improvement. J Am Geriatr Soc 52 (2004) 1051-1059
25. Repetto L., and Balducci L. A case for geriatric oncology. Lancet 3 (2002) 289-297
26. Rabow M.W., Fair J.M., Hardie G.E., et al. An evaluation of the end-of-life care content in leading neurology textbooks. Neurology 55 (2000) 893-894
27. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th Ed. (2000), American Psychiatric Association, Washington, DC [text revision]
28. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12 (1975) 189-198
29. Portney L.G., and Watkins M.P. Foundations of clinical research: applications to practice (2000), Prentice Hall Health, Upper Saddle River, NJ
30. Meyers C.A., Byrne K.S., and Komaki R. Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 12 (1995) 231-235
31. Casarett D.J., and Inouye S.K. Diagnosis and management of delirium near end of life. Ann Intern Med 135 (2001) 32-40
32. Freeman J.R., and Broshek D.K. Assessing cognitive dysfunction in breast cancer: what are the tools?. Clin Breast Cancer 3 Suppl 3 (2002) S91-S99
33. Meyers C.A., and Wefel J.S. The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, and, buts or sensitivity. J Clin Oncol 21 (2003) 3557-3558